• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估早期检测的乳腺癌肿瘤生长模型——综述与模拟研究

Tumour Growth Models of Breast Cancer for Evaluating Early Detection-A Summary and a Simulation Study.

作者信息

Strandberg Rickard, Abrahamsson Linda, Isheden Gabriel, Humphreys Keith

机构信息

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden.

Center for Primary Health Care Research, Lund University, 205 02 Malmö, Sweden.

出版信息

Cancers (Basel). 2023 Jan 31;15(3):912. doi: 10.3390/cancers15030912.

DOI:10.3390/cancers15030912
PMID:36765870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9913080/
Abstract

With the advent of nationwide mammography screening programmes, a number of natural history models of breast cancers have been developed and used to assess the effects of screening. The first half of this article provides an overview of a class of these models and describes how they can be used to study latent processes of tumour progression from observational data. The second half of the article describes a simulation study which applies a continuous growth model to illustrate how effects of extending the maximum age of the current Swedish screening programme from 74 to 80 can be evaluated. Compared to no screening, the current and extended programmes reduced breast cancer mortality by 18.5% and 21.7%, respectively. The proportion of screen-detected invasive cancers which were overdiagnosed was estimated to be 1.9% in the current programme and 2.9% in the extended programme. With the help of these breast cancer natural history models, we can better understand the latent processes, and better study the effects of breast cancer screening.

摘要

随着全国性乳腺钼靶筛查项目的出现,人们开发了一些乳腺癌自然史模型,并用于评估筛查效果。本文前半部分概述了这类模型中的一种,并描述了如何利用它们从观察数据中研究肿瘤进展的潜在过程。文章后半部分描述了一项模拟研究,该研究应用连续增长模型来说明如何评估将瑞典当前筛查项目的最大年龄从74岁延长至80岁的效果。与不进行筛查相比,当前项目和延长后的项目分别将乳腺癌死亡率降低了18.5%和21.7%。据估计,当前项目中筛查发现的浸润性癌症被过度诊断的比例为1.9%,延长后的项目中这一比例为2.9%。借助这些乳腺癌自然史模型,我们可以更好地理解潜在过程,并更好地研究乳腺癌筛查的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5cc/9913080/9f0af22ed391/cancers-15-00912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5cc/9913080/258d6830b5e0/cancers-15-00912-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5cc/9913080/6ad86faa1b98/cancers-15-00912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5cc/9913080/4257b304cf37/cancers-15-00912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5cc/9913080/9f0af22ed391/cancers-15-00912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5cc/9913080/258d6830b5e0/cancers-15-00912-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5cc/9913080/6ad86faa1b98/cancers-15-00912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5cc/9913080/4257b304cf37/cancers-15-00912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5cc/9913080/9f0af22ed391/cancers-15-00912-g003.jpg

相似文献

1
Tumour Growth Models of Breast Cancer for Evaluating Early Detection-A Summary and a Simulation Study.用于评估早期检测的乳腺癌肿瘤生长模型——综述与模拟研究
Cancers (Basel). 2023 Jan 31;15(3):912. doi: 10.3390/cancers15030912.
2
Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.与乳腺癌钼靶筛查相关的过度诊断和过度治疗:一项基于人群数据校准的模拟研究。
Breast. 2016 Aug;28:60-6. doi: 10.1016/j.breast.2016.04.013. Epub 2016 May 27.
3
Mammography screening: A major issue in medicine.乳腺 X 光筛查:医学中的一个重大问题。
Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20.
4
5
Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.荷兰乳腺钼靶筛查的有效性及过度诊断:基于人群的研究
BMJ. 2017 Dec 5;359:j5224. doi: 10.1136/bmj.j5224.
6
Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.对英国40至49岁女性因乳腺钼靶筛查导致的乳腺癌过度诊断进行建模。
Breast Cancer Res. 2012 Nov 29;14(6):R152. doi: 10.1186/bcr3365.
7
Estimating latent, dynamic processes of breast cancer tumour growth and distant metastatic spread from mammography screening data.从乳房X光筛查数据中估计乳腺癌肿瘤生长和远处转移扩散的潜在动态过程。
Stat Methods Med Res. 2022 May;31(5):862-881. doi: 10.1177/09622802211072496. Epub 2022 Feb 1.
8
Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.在瑞典乳腺 X 光筛查计划中检出的乳腺癌的自然史:一项队列研究。
Lancet Oncol. 2011 Nov;12(12):1118-24. doi: 10.1016/S1470-2045(11)70250-9. Epub 2011 Oct 11.
9
Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.因乳腺 X 光筛查导致的必然过度诊断:美国女性的直接评估
Radiology. 2018 May;287(2):391-397. doi: 10.1148/radiol.2017171622. Epub 2017 Dec 21.
10
Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.利用短期趋势和未受过度诊断病例污染的领先时间估计来评估过度诊断:挪威乳腺癌筛查项目的结果。
J Med Screen. 2016 Dec;23(4):192-202. doi: 10.1177/0969141315623980. Epub 2016 Mar 2.

引用本文的文献

1
Optimizing breast cancer screening strategies for women with different BMI levels in Ghana: A simulation-based study on BMI-dependent tumor growth model.优化加纳不同BMI水平女性的乳腺癌筛查策略:基于BMI依赖性肿瘤生长模型的模拟研究
PLOS Glob Public Health. 2025 Jul 28;5(7):e0004953. doi: 10.1371/journal.pgph.0004953. eCollection 2025.
2
Evaluation of optimal strategies for breast cancer screening in Ghana: A simulation study based on a continuous tumor growth model.加纳乳腺癌筛查最佳策略评估:基于连续肿瘤生长模型的模拟研究
PLoS One. 2025 Jun 17;20(6):e0323485. doi: 10.1371/journal.pone.0323485. eCollection 2025.
3

本文引用的文献

1
A unifying framework for continuous tumour growth modelling of breast cancer screening data.用于乳腺癌筛查数据连续肿瘤生长建模的统一框架。
Math Biosci. 2022 Nov;353:108897. doi: 10.1016/j.mbs.2022.108897. Epub 2022 Aug 28.
2
Change in effectiveness of mammography screening with decreasing breast cancer mortality: a population-based study.乳腺癌死亡率降低背景下乳腺 X 线筛查效果的变化:基于人群的研究。
Eur J Public Health. 2022 Aug 1;32(4):630-635. doi: 10.1093/eurpub/ckac047.
3
Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort.
A stochastic modelling framework for cancer patient trajectories: combining tumour growth, metastasis, and survival.
一种用于癌症患者病程的随机建模框架:结合肿瘤生长、转移和生存情况。
J Math Biol. 2025 May 22;90(6):65. doi: 10.1007/s00285-025-02229-6.
4
The natural history of ductal carcinoma in situ: development, validation, and estimated outcomes of the SimDCIS model.导管原位癌的自然史:SimDCIS模型的开发、验证及预期结果
Breast Cancer Res Treat. 2025 May;211(1):223-231. doi: 10.1007/s10549-025-07639-0. Epub 2025 Mar 1.
美国乳腺筛查队列中乳腺癌过度诊断的评估。
Ann Intern Med. 2022 Apr;175(4):471-478. doi: 10.7326/M21-3577. Epub 2022 Mar 1.
4
Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort.估算瑞典乳腺 X 光筛查队列中乳腺癌发病和生长的分布情况。
Cancer Epidemiol Biomarkers Prev. 2022 Mar 1;31(3):569-577. doi: 10.1158/1055-9965.EPI-21-1011.
5
The current status of risk-stratified breast screening.风险分层乳腺癌筛查的现状。
Br J Cancer. 2022 Mar;126(4):533-550. doi: 10.1038/s41416-021-01550-3. Epub 2021 Oct 26.
6
Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.反思 CISNET 二十年的乳腺癌建模:对未来癌症系统建模工作的建议。
PLoS Comput Biol. 2021 Jun 17;17(6):e1009020. doi: 10.1371/journal.pcbi.1009020. eCollection 2021 Jun.
7
Cost-effectiveness of risk-based breast cancer screening: A systematic review.基于风险的乳腺癌筛查的成本效益:一项系统综述。
Int J Cancer. 2021 Apr 12. doi: 10.1002/ijc.33593.
8
Random effects models of lymph node metastases in breast cancer: quantifying the roles of covariates and screening using a continuous growth model.乳腺癌淋巴结转移的随机效应模型:使用连续增长模型量化协变量和筛查的作用。
Biometrics. 2022 Mar;78(1):376-387. doi: 10.1111/biom.13430. Epub 2021 Feb 7.
9
Translating Cancer Risk Prediction Models into Personalized Cancer Risk Assessment Tools: Stumbling Blocks and Strategies for Success.将癌症风险预测模型转化为个性化癌症风险评估工具:成功的绊脚石和策略。
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2389-2394. doi: 10.1158/1055-9965.EPI-20-0861. Epub 2020 Oct 12.
10
Modeling the natural history of ductal carcinoma in situ based on population data.基于人群数据对导管原位癌自然史进行建模。
Breast Cancer Res. 2020 May 27;22(1):53. doi: 10.1186/s13058-020-01287-6.